A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients

Abstract Background Adrenal androgens play an important role in the development of castration-resistant prostate cancer therapeutics. The effect of gonadotropin-releasing hormone (GnRH) antagonists on adrenal androgens has not been studied sufficiently. We measured testicular and adrenal androgen le...

Full description

Bibliographic Details
Main Authors: Yoshiyuki Miyazawa, Yoshitaka Sekine, Takahiro Syuto, Masashi Nomura, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata, Kazuto Ito, Kazuhiro Suzuki
Format: Article
Language:English
Published: BMC 2017-08-01
Series:BMC Urology
Subjects:
Prostate cancer
GnRH antagonist
Adrenal androgen
Online Access:http://link.springer.com/article/10.1186/s12894-017-0261-z

Internet

http://link.springer.com/article/10.1186/s12894-017-0261-z

Similar Items